A detailed history of Jacobsen Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Jacobsen Capital Management holds 806 shares of AMGN stock, worth $237,391. This represents 0.11% of its overall portfolio holdings.

Number of Shares
806
Previous 798 1.0%
Holding current value
$237,391
Previous $249,000 4.02%
% of portfolio
0.11%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$309.38 - $337.38 $2,475 - $2,699
8 Added 1.0%
806 $259,000
Q2 2024

Jul 23, 2024

BUY
$262.75 - $319.31 $7,619 - $9,259
29 Added 3.77%
798 $249,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $537 - $649
2 Added 0.26%
769 $218,000
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $196,121 - $221,248
767 New
767 $220,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jacobsen Capital Management Portfolio

Follow Jacobsen Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobsen Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Jacobsen Capital Management with notifications on news.